MXCT.O (MXCT.O) News
Follow MXCT.O (MXCT.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Cell — engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
(This story was generated using AI and automation, please see disclaimer ) Overview Cell-engineering firm's preliminary Q3 revenue rose 26% yr/yr, beating analyst expectations Company raised full-year 2026 revenue guidan
EARNINGS | Oct 14, 2026, 12:15 PM UTC
H
MaxCyte raises full — year 2026 revenue guidance to about $34 million
MaxCyte raised full-year 2026 revenue guidance to about $34 million from $30 million-$32 million. Core business revenue outlook increased to about $28 million from $25 million-$27 million. SPL Program-related revenue for
EARNINGS | Oct 14, 2026, 12:08 PM UTC